Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteclementiapharma.com
CategoryBioTech
Employees

Offices

Dorval, CAN
1375 TransCanada Highway
Suite 200
Dorval, H9P 2W8, CAN

People

Founder and CEO
Chief Medical Officer
Chief Development Officer

Funding

TOTAL $22.5M
FUNDING TOTAL $22.5M
Series A, 1/2014
OrbiMed Advisors
BDC Venture Capital
$22.5M

Tags

Clementia Pharmaceuticals

Clementia is a privately-held, clinical stage biotechnology company dedicated to the development and commercialization of treatments for people living with rare diseases by exploiting the use of novel Retinoic acid receptor gamma agonists (RARγ) to address diseases of heterotopic ossification, including Fibrodysplasia Ossificans Progressiva.

Recent Milestones

Videos

Screenshots

Clementia Pharmaceuticals screenshot
Above: Homepage
Uploaded: 1/9/14

Sources

  1. Clementia Pharmaceuticals Closes $22.5M Series A Financing (finsmes.com) [edit]
Edit This Page
Last Edited 2/18/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy